News

Researchers have identified a recessive mutation as a defect in the circadian regulator gene Cryptochrome 1.

A mushroom that infects and kills insects has been known to produce a bioactive compound that could be used as an antiviral or cancer drug, but growing these fungi in the lab has proved to be challenging, until now.

New drugs that activate the adrenaline receptor rather than opioid receptors could be the future of pain relief medication that isn't addictive.

Researchers have developed a method to swiftly identify natural products from bacteria using a laboratory automation system called iBioFAB, which could lead to the development of new antibiotics.

Two drugs that inhibit precancerous cell progression have been shown to reverse a process that precedes pancreatic cancer, hopefully enabling earlier treatment for the disease.

Researchers have identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme.

Researchers have developed a new approach to delivering immunotherapy agents directly to cells in the tumor microenvironment, using an acid-seeking molecule called pHLIP®.

Researchers have shown that the antibiotic D-Cycloserine increases the effectiveness of transcranial magnetic stimulation for people with major depressive disorder.

Researchers have created an artificial intelligence model called CODE-AE that could significantly improve the accuracy, time and cost of the drug development process. Researchers hope this will accelerate drug discovery and precision medicine.

According to research, a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug can suppress the growth of triple-negative breast cancer cells synergistically.